Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage
Sponsored by Laniado Hospital
About this trial
Last updated 8 years ago
Study ID
0148-16-LND-2016121
Status
Recruiting
Type
Observational
Placebo
No
Accepting
1 to 3 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 8 years ago
What is this trial about?
Intraventricular hemorrhage (IVH) is the most commonly recognized cerebral lesion on
ultrasound in extremely preterm infants. Papile classification is commonly used to grade
the severity of IVH. Grade III-IV IVH and other lesions noted on ultrasound including
periventricular leukomalacia (pvl) porencephaly, and ventriculomegaly are well Documented
to be associated with adverse neurodevelopmental outcomes.
However, the true impact of lower-grade IVH on the neurodevelopment of these extreme
preterm infants has not been well described.
Also Neurodevelopmental outcome for neonatal non-traumatic Intra Cranial Hemorrhage (ICH)
is not well established.
The aim of this study is to look retrospectively at babies with neonatal IVH or ICH and
follow their radiological, cognitive, motor and functional outcomes.
The study will focus on postnatal files, and on images performed as part of the child's
follow-up during hospitalization and after discharge.
What are the participation requirements?
Inclusion Criteria
newborns or premature babies who suffered intra-cranial or intra-ventricular hemorrhage children who are followed by PI in the neurosurgical clinic in Laniado hospital and suffered from ICH or IVH and were treated elsewhere after birth -
Exclusion Criteria
loss to followup within the first year after birth -
Locations
Location
Status
Recruiting